ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Approves 8 Cancer Centers As Comprehensive

October 4, 1991

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

Review Of Cancer Center supports Grants Needs Refocus On Science, Advisors Say

October 18, 1996